Provided by Tiger Fintech (Singapore) Pte. Ltd.

WUXI BIO

23.750
+0.000
Volume:41.70M
Turnover:991.18M
Market Cap:97.54B
PE:27.17
High:24.500
Open:24.100
Low:23.400
Close:23.750
Loading ...

Investors three-year losses continue as WuXi Biologics (Cayman) (HKG:2269) dips a further 6.4% this week, earnings continue to decline

Simply Wall St.
·
02 Nov 2024

BRIEF-UBS Group's Long Position In H-Shares Of Wuxi Apptec Decreases To 4.91% On Oct 28 - HKEX

Reuters
·
01 Nov 2024

Stock Track | WUXI BIO Soars 7.9% as China Property Sales Rebound Brightens Growth Outlook

Stock Track
·
25 Oct 2024

Stock Track | WUXI BIO Surges 7.65% on Robust China Property Market Outlook

Stock Track
·
25 Oct 2024

Hong Kong Stocks Rise to Pare Weekly Loss as China Growth Prospects Brighten

Tiger Newspress
·
25 Oct 2024

Hong Kong Most Actives

Dow Jones
·
17 Oct 2024

Selling WuXi Biologics (Cayman) Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall St.
·
15 Oct 2024

WuXi XDC Cayman Shareholders to Vote on Annual Cap Boost on Oct. 25

MT Newswires Live
·
09 Oct 2024

Hong Kong Shares Fall; Markets Await Details on China Fiscal Measures -- Market Talk

Dow Jones
·
09 Oct 2024

Stock Track | WUXI BIO Surges 16% on Plans to Divest Units Amid US Restrictions

Stock Track
·
05 Oct 2024

Stock Track | WUXI BIO Soars 16% on Plans to Sell Units Amid US Restrictions

Stock Track
·
04 Oct 2024

Hong Kong Stocks End Week Higher as Tech Counters Rally

MT Newswires Live
·
04 Oct 2024

WuXi Companies' Shares Surge on Report of Potential Asset Sales

Dow Jones
·
04 Oct 2024

Market Chatter: WuXi AppTec, WuXi Biologics Seek Pharma Operations Sale Amid Pending US Restrictions

MT Newswires Live
·
04 Oct 2024

BUZZ-HK shares of WuXi Bio, WuXi AppTec jump on report cos explore sale of pharma operations

Reuters
·
04 Oct 2024

UPDATE 1-China's WuXi explores sale of pharma operations as US restrictions loom, FT reports

Reuters
·
03 Oct 2024